Paget's disease of the breast differential diagnosis: Difference between revisions
Preeti Singh (talk | contribs) No edit summary |
Preeti Singh (talk | contribs) No edit summary |
||
Line 26: | Line 26: | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign or Malignant | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign or Malignant | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ||
! colspan=" | ! colspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations | ||
! rowspan="2" |Para-clinical findings | ! rowspan="2" |Para-clinical findings | ||
| rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold Standard | | rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold Standard | ||
| rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Associated factors''' | | rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Associated factors''' | ||
|- | |- | ||
! colspan=" | ! colspan="5" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms | ||
! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ! colspan="2" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination | ||
|- | |- | ||
Line 39: | Line 39: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nipple Discharge | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nipple Discharge | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Erythema | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Erythema | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Involved areas | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Involved areas | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mastalgia | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mastalgia | ||
Line 47: | Line 46: | ||
! rowspan="20" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin disorders | ! rowspan="20" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin disorders | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Paget's disease of the breast | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |Paget's disease of the breast | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |[[Malignant]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" |Ulcerated, crusted, or scaling lesion on the nipple that extends to the areolar region | | align="center" style="background:#F5F5F5;" |Ulcerated, crusted, or scaling lesion on the nipple that extends to the areolar region | ||
| align="center" style="background:#F5F5F5;" |± | | align="center" style="background:#F5F5F5;" |± | ||
| align="center" style="background:#F5F5F5;" |+ | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |Breast | | align="center" style="background:#F5F5F5;" |Breast | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 63: | Line 61: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Extramammary Paget's disease]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Extramammary Paget's disease]] | ||
| align="center" style="background:#F5F5F5;" |[[Malignant]] | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 72: | Line 71: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |[[Biopsy]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
Line 88: | Line 85: | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" | – | ||
| align="center" style="background:#F5F5F5;" | – | | align="center" style="background:#F5F5F5;" | – | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Young children -[[Scalp]], [[cheeks]] amd [[extensor]] surface | * Young children -[[Scalp]], [[cheeks]] amd [[extensor]] surface | ||
Line 129: | Line 125: | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | Surrounding the area in contact with the offending agent | | align="center" style="background:#F5F5F5;" | Surrounding the area in contact with the offending agent | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
Line 153: | Line 148: | ||
| align="center" style="background:#F5F5F5;" | Well-circumscribed, pink [[papules]] and symmetrically distributed cutaneous [[plaques]] with silvery scales | | align="center" style="background:#F5F5F5;" | Well-circumscribed, pink [[papules]] and symmetrically distributed cutaneous [[plaques]] with silvery scales | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 198: | Line 192: | ||
[[Bleeding]] from the lesion may be present | [[Bleeding]] from the lesion may be present | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 227: | Line 220: | ||
* variable size | * variable size | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 256: | Line 248: | ||
* Superficial scaly patch | * Superficial scaly patch | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 277: | Line 268: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Intraductal papilloma|Benign intraductal papilloma]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Intraductal papilloma|Benign intraductal papilloma]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 292: | Line 282: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Pagetoid dyskeratosis | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |Pagetoid dyskeratosis | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 308: | Line 297: | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Duct ectasia of breast|Lactiferous duct ectasia]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Duct ectasia of breast|Lactiferous duct ectasia]] | ||
| align="center" style="background:#F5F5F5;" |[[Benign]] | | align="center" style="background:#F5F5F5;" |[[Benign]] | ||
| align="center" style="background:#F5F5F5;" |* Common among [[perimenopausal]]<nowiki/>women | | align="center" style="background:#F5F5F5;" |* Common among [[perimenopausal]]<nowiki/> women | ||
* Usually resolve spontaneously | * Usually resolve spontaneously | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 325: | Line 313: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Nipple duct adenoma | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |Nipple duct adenoma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 340: | Line 327: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |Benign Toker cell hyperplasia | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |Benign Toker cell hyperplasia | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 356: | Line 342: | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Breast abscess]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Breast abscess]] | ||
| align="center" style="background:#F5F5F5;" |[[Benign]] | | align="center" style="background:#F5F5F5;" |[[Benign]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 374: | Line 359: | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Mondors disease]] | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Mondors disease]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 396: | Line 380: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" |± | | align="center" style="background:#F5F5F5;" |± | ||
Line 424: | Line 407: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |[[Biopsy]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
|- | |- |
Revision as of 23:25, 24 February 2019
Paget's disease of the breast Microchapters |
Differentiating Paget's disease of the breast from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Paget's disease of the breast differential diagnosis On the Web |
American Roentgen Ray Society Images of Paget's disease of the breast differential diagnosis |
Paget's disease of the breast differential diagnosis in the news |
Blogs on Paget's disease of the breast differential diagnosis |
Directions to Hospitals Treating Paget's disease of the breast |
Risk calculators and risk factors for Paget's disease of the breast differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]
Overview
Paget's disease of the breast must be differentiated from atopic dermatitis, eczema, psoriasis, malignant melanoma, Bowen's disease, basal cell carcinoma, and pagetoid dyskeratosis.[1][2]
Differential Diagnosis
Paget’s disease of the breast must be differentiated from other benign and malignant processes of nipple-areola complex such as:[1][2]
- Atopic dermatitis
- Chronic contact dermatitis
- Lactiferous duct ectasia
- Chronic eczema
- Psoriasis
- Nipple duct adenoma
- Malignant melanoma
- Bowen’s disease
- Superficial basal cell carcinoma
- Benign intraductal papilloma
- Pagetoid dyskeratosis
Paget's disease of the breast is often misdiagnosed as nipple eczema
Category | Diseases | Benign or Malignant | Etiology | Clinical manifestations | Para-clinical findings | Gold Standard | Associated factors | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||
Histopathology | |||||||||||||
Rash | Nipple Discharge | Erythema | Involved areas | Mastalgia | Breast Exam | Other | |||||||
Skin disorders | Paget's disease of the breast | Malignant | Ulcerated, crusted, or scaling lesion on the nipple that extends to the areolar region | ± | + | Breast | appearance varies from small flaps to well-delimited erythematous and desquamative plaques with irregular borders | ||||||
Extramammary Paget's disease | Malignant | Biopsy | |||||||||||
Atopic dermatitis
(Eczema) |
Benign |
|
– | – |
|
– |
|
|
|
| |||
Allergic contact dermatitis[3] | Benign |
|
Erythematous well-demarcated papules | – | – | Surrounding the area in contact with the offending agent | + |
|
|
| |||
Psoriasis | Benign |
|
Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales | – | + |
|
+ |
|
|
Risk factors include
| |||
Malignant melanoma | Malignant |
|
|
–
Bleeding from the lesion may be present |
|
| |||||||
Bowen’s disease | Benign can turn malignant |
|
– |
|
|
|
| ||||||
Superficial basal cell carcinoma | Malignant |
|
– |
|
|
|
| ||||||
Benign intraductal papilloma | |||||||||||||
Pagetoid dyskeratosis | |||||||||||||
Lactiferous duct ectasia | Benign | * Common among perimenopausal women
|
Ultrasound:
|
||||||||||
Nipple duct adenoma | |||||||||||||
Benign Toker cell hyperplasia | |||||||||||||
Breast abscess | Benign | + |
|
|
|||||||||
Mondors disease | |||||||||||||
Mastitis |
|
± |
|
|
|||||||||
Inflammatory Breast Cancer | Malignant | Biopsy |
References
- ↑ 1.0 1.1 Gaspari, Eleonora; Ricci, Aurora; Liberto, Valeria; Scarano, Angela Lia; Fornari, Maria; Simonetti, Giovanni (2013). "An Unusual Case of Mammary Paget's Disease Diagnosed Using Dynamic Contrast-Enhanced MRI". Case Reports in Radiology. 2013: 1–5. doi:10.1155/2013/206235. ISSN 2090-6862.
- ↑ 2.0 2.1 Lopes Filho, Lauro Lourival; Lopes, Ione Maria Ribeiro Soares; Lopes, Lauro Rodolpho Soares; Enokihara, Milvia M. S. S.; Michalany, Alexandre Osores; Matsunaga, Nobuo (2015). "Mammary and extramammary Paget's disease". Anais Brasileiros de Dermatologia. 90 (2): 225–231. doi:10.1590/abd1806-4841.20153189. ISSN 1806-4841.
- ↑ Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF (2009). "Allergic and irritant contact dermatitis". Eur J Dermatol. 19 (4): 325–32. doi:10.1684/ejd.2009.0686. PMID 19447733.